6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07638 | branched tetrapeptide Schiff bases derivative 4a | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |
| dbacp07639 | branched tetrapeptide Schiff bases derivative 4b | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |
| dbacp07640 | branched tetrapeptide Schiff bases derivative 4c | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |
| dbacp07641 | branched tetrapeptide Schiff bases derivative 5c | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |
| dbacp07642 | branched tetrapeptide Schiff bases derivative 5d | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |
| dbacp07643 | branched tetrapeptide Schiff bases derivative 5e | Figure given in Scheme 1 | Synthetic | p53 stabilization and LDHA inhibition | MTT assay | MCF-7 | Breast Cancer | IC50 between 8.12 ± 0.14 to 17.55 ± 0.27 μM |